Frequently Asked Questions
The market is segmented based on , By Type (Double Deficit Dyslexia, Visual Dyslexia, Phonological Dyslexia and Others), Therapy Type (Occupational Therapy, Speech Therapy and Cognitive Behavioural Therapy), Drug Class (Antihistamine, Central Nervous Stimulant, Anti-Myoclonic and Others), Drugs (Cyclizine, Meclizine, Dimenhydrinate, Methylphenidate and Others), Route of Administration (Oral and Injectable), End Users (Psychiatric Institutions, Rehabilitation Centres, Home Care and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others) – Industry Trends and Forecast to 2030.
.
The Global Dyslexia Treatment Market size was valued at USD 4096.10 USD Billion in 2022.
The Global Dyslexia Treatment Market is projected to grow at a CAGR of 6.3% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
